Search results
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of...
Morningstar· 1 day agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...
New Study Shows Petadolex Butterbur may be an Effective Supplement for Migraine Management
Benzinga· 6 days agoA new review in the journal Practical Neurology highlights the efficacy of the supplement Petadolex in preventing migraines. The comprehensive review of "Nutraceuticals for Migraine Management ...
Enzolytics, Inc. Poised to Invest Alongside Sagaliam Acquisition Corp in Revolutionary Room...
Morningstar· 2 days agoALLEN, TX / ACCESSWIRE / June 3, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com")(the "Company") is thrilled to announce that the Company and Sagaliam Acquisition ...
Chickenpox vs. Shingles: Causes, Symptoms, and Treatments
Health.com· 3 days agoHere's what you need to know about shingles and chickenpox, including symptoms, causes, and...
Open Letter to Shareholders From US Nuclear's CEO
Digital Journal· 2 days agoLOS ANGELES, CA - (NewMediaWire) - June 03, 2024 - US Nuclear Corp. (OTC-QB: UCLE) continues to be the industry technology leader in its sector, and continues to find solutions ...
Breakthrough Bleeding on the Pill Is Normal. Here's How Long You Can Expect It To Last
Well and Good· 5 days agoTaking the birth control pill comes with many bonuses. There’s the biggie (preventing an unwanted...
Stress *Could* Be the Reason Behind Your Daily Diarrhea—But There Are Other Causes (Beyond Being...
Well and Good· 2 days agoIf you've been feeling a rumbling in your stomach every day (promptly followed by loose stools), but...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks· 3 days agoFree Report) issued a statement disagreeing with the ruling by a state court in Delaware to allow jury trials for cases, which claim GSK’s discontinued heartburn drug Zantac ...
Victory Square Technologies Reports Q1 2024 Financial Results
Digital Journal· 5 days agoTopline Revenue for the three-months ended March 31, 2024, was $5,052,069Cash & liquid securities approx. $4,410,203Notable Portfolio Company Highlights: Hydreight, GameOn, XR Immersive, Covalent ...
...Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum...
Benzinga· 5 days agoMDNA11 demonstrates durable response in pancreatic cancer patient with 100% regression of target and non-target lesions for over 104 weeks and continues to show remission 4 months after stopping treatment Melanoma